> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Haleon Recalls 8 Robitussin Lots
- URL: https://www.fdaweb.com/haleon-recalls-8-robitussin-lots/
- Published: 2024-01-24T12:00:00.000Z
- Updated: 2026-09-14T14:21:01.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5156209

Haleon is recalling eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult due to concerns about microbial contamination. “In immunocompromised individuals, the use of the affected product could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection,” a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/haleon-issues-voluntary-nationwide-recall-robitussin-honey-cf-max-day-adult-and-robitussin-honey-cf?ref=fdaweb.com) says. To date, Haleon says it has not received any adverse event reports related to the recall. Both products are indicated for the temporary relief of symptoms occurring with cold or flu, hay fever, or other respiratory allergies.